FOLH1 and prostate cancer: Luiting et al. conducted a systematic review on PET-CT PSMA for detecting lymph node metastases in primary prostate cancer, reporting specificity ranging from 80% to 100%, while sensitivity varied between 33.3% and 100% [12].